VR1

About:

VR1 develops and manufactures non-prescription medicine for the treatment of migraine and severe headaches.

Description:

VR1 Corp develops and manufactures non prescription medicines for the treatment of migraine and severe headaches. The company was founded in 2012 and is based in New York, New York.

Total Funding Amount:

$2.39M

Estimated Revenue Range:

Less than $1M

Headquarters Location:

New York, New York, United States

Founded Date:

2012-01-01

Contact Email:

info(AT)vr1med.com

Founders:

Anjan Chatterjee

Number of Employees:

Last Funding Date:

2014-09-16

IPO Status:

Private

Industries: